These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38436114)

  • 1. Clinical and immunological features of COVID-19 in patients with anti-MDA5 dermatomyositis during the omicron wave in Chongqing, China.
    Wu N; Chen Z; Zha G; Deng Z; Huang W; Cai D; Peng M; Hu P; Tang L; Ren H
    J Med Virol; 2024 Mar; 96(3):e29493. PubMed ID: 38436114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of exhausted CD8+ T cells associates with increased pulmonary fungal infection risk in anti-melanoma differentiation associated gene 5 dermatomyositis.
    Xu YT; Cao ZY; Lin S; Shu XM; Lu X; Wang GC; Peng QL
    Clin Exp Rheumatol; 2024 Feb; 42(2):237-245. PubMed ID: 38153165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum B-cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease.
    Matsushita T; Kobayashi T; Kano M; Hamaguchi Y; Takehara K
    J Dermatol; 2019 Dec; 46(12):1190-1196. PubMed ID: 31631384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of thirty-two patients with anti-melanoma differentiation-associated gene 5 antibodies.
    Huang W; Ren F; Wang Q; Luo L; Zhou J; Huang D; Pan Z; Tang L
    Clin Exp Rheumatol; 2019; 37(5):803-807. PubMed ID: 30767866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and immunogenicity after Omicron breakthrough infection in patients with chronic hepatitis B infection: A longitudinal observational study.
    Zha G; Chen Z; Wu N; Huang T; Deng Z; Cai D; Peng M; Hu P; Ren H
    J Med Virol; 2024 Mar; 96(3):e29548. PubMed ID: 38511555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
    Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC
    Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559
    [No Abstract]   [Full Text] [Related]  

  • 7. Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody.
    Hosono Y; Nakashima R; Serada S; Murakami K; Imura Y; Yoshifuji H; Ohmura K; Naka T; Mimori T
    J Autoimmun; 2017 Feb; 77():116-122. PubMed ID: 27919567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ECG Changes Through Immunosuppressive Therapy Indicate Cardiac Abnormality in Anti-MDA5 Antibody-Positive Clinically Amyopathic Dermatomyositis.
    Matsuo T; Sasai T; Nakashima R; Kuwabara Y; Kato ET; Murakami I; Onizawa H; Akizuki S; Murakami K; Hashimoto M; Yoshifuji H; Tanaka M; Morinobu A; Mimori T
    Front Immunol; 2021; 12():765140. PubMed ID: 35069538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of anti-melanoma differentiation associated gene 5 (MDA5) IgG subclasses in MDA5+ dermatomyositis.
    Chen M; Zhao Q; Diao L; Xue K; Ruan Y; Xue F; Li J; Shi R; Pan M; Zheng J; Cao H
    Rheumatology (Oxford); 2021 Dec; 61(1):430-439. PubMed ID: 33742662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis.
    Chen F; Wang D; Shu X; Nakashima R; Wang G
    Rheumatol Int; 2012 Dec; 32(12):3909-15. PubMed ID: 22198664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and prognostic implications of peripheral blood lymphocyte subsets in patients with anti-MDA5 antibody positive dermatomyositis-interstitial lung disease.
    Ren FP; Chen Q; Yao SS; Feng L; Xue XY; Zhao WC; Wang D; Zhao ZL; Gu SW; Li T; Shen YW; Gao L; Zang XL; Bao XY; Tong ZH
    BMC Pulm Med; 2023 Oct; 23(1):411. PubMed ID: 37898737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between anti-melanoma differentiation-associated gene 5 antibody and demographics, clinical characteristics and laboratory results of patients with dermatomyositis: A systematic meta-analysis.
    Li J; Liu Y; Li Y; Li F; Wang K; Pan W; Meng D
    J Dermatol; 2018 Jan; 45(1):46-52. PubMed ID: 28983955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case-control study.
    Ji Q; Pan W; Zhang D; Hou Y; Wang Z
    Front Immunol; 2023; 14():1237209. PubMed ID: 38098481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DRB1 Alleles as Genetic Risk Factors for the Development of Anti-MDA5 Antibodies in Patients with Dermatomyositis.
    Chen Z; Wang Y; Kuwana M; Xu X; Hu W; Feng X; Wang H; Kimura A; Sun L
    J Rheumatol; 2017 Sep; 44(9):1389-1393. PubMed ID: 28711882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis.
    Li L; Wang Q; Yang F; Wu C; Chen S; Wen X; Liu C; Li Y
    Oncotarget; 2017 Apr; 8(16):26552-26564. PubMed ID: 28460448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.
    Sato S; Murakami A; Kuwajima A; Takehara K; Mimori T; Kawakami A; Mishima M; Suda T; Seishima M; Fujimoto M; Kuwana M
    PLoS One; 2016; 11(4):e0154285. PubMed ID: 27115353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.
    Sakamoto S; Okamoto M; Kaieda S; Fujimoto K; Nagata S; Tominaga M; Nakamura M; Zaizen Y; Nouno T; Koga T; Kawayama T; Kuwana M; Ida H; Hoshino T
    Respir Investig; 2018 Nov; 56(6):464-472. PubMed ID: 30150008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study.
    Wang G; Wang Q; Wang Y; Liu C; Wang L; Chen H; Jiao T; Hu C; Lei X; Guo L; Ren L; Li M; Zhao Y; Zeng X; Zhang D; Cao B; Wang J
    Front Immunol; 2021; 12():791348. PubMed ID: 34987516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    Fujisawa T; Hozumi H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    J Rheumatol; 2019 Aug; 46(8):935-942. PubMed ID: 31092718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratin 19 fragment is associated with severity and poor prognosis of interstitial lung disease in anti-MDA5 antibody-positive dermatomyositis.
    Gui X; Ma M; Ding J; Shi S; Xin X; Qiu X; Zhang Y; Qiu Y; Cao M; Huang M; Cao M; Dai J; Cai H; Xiao Y
    Rheumatology (Oxford); 2021 Aug; 60(8):3913-3922. PubMed ID: 33501503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.